Information about Bsb Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0792.204.443

VAT liability
Yes
Established
07-10-2022
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Bsb Pharma

2025 2024 2023
Income statement
Profit/Loss € 9,660 -69% € 31,567 -19% € 38,996
Gross margin € 51,324 16% € 44,132 -19% € 54,412
Balance sheet
Balance sheet total € 118,927 33% € 89,393 39% € 64,430
Equity € 79,924 14% € 70,264 78% € 39,496
Debts € 39,004 104% € 19,130 -23% € 24,934

Publications from Bsb Pharma

Date Publication
23-09-2026 Registered Office Relocation (FR)
27-05-2026 Registered Office (FR)
11-10-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Bsb Pharma?
The VAT number of Bsb Pharma is BE 0792.204.443.
Wat is the PEPPOL ID of Bsb Pharma?
The PEPPOL ID of Bsb Pharma is 0208:0792204443. Log in or start a free trial to see the full overview.
When was Bsb Pharma founded?
Bsb Pharma was founded on 07-10-2022.
What is the address of Bsb Pharma?
The current registered office of Bsb Pharma is located at Rue de Grand-Bigard 405, 1082 Berchem-Sainte-Agathe.
When was the last time Bsb Pharma filed their annual financial statements?
The most recent financial statements of Bsb Pharma were filed on 13-04-2026.
How many employees does Bsb Pharma have?
There are currently no employees working at Bsb Pharma or no workforce information is available.
What is the annual turnover of Bsb Pharma?
At the time of its most recent financial statements, Bsb Pharma did not publish any turnover figures. Bsb Pharma reported a gross margin of €51,323.99.

Sources